SAFGANDO

What this means for you

This application is over — abandoned 27 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.

Record

Serial number

98381206

Mark type

Stylized text

Filed

29 Jan 2024

Published for opposition

28 Jan 2025

Abandoned

27 Oct 2025

Attorney of record

Brandon P. Leahy

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement

Owner

• Renibus Therapeutics, Inc., Southlake, TX, US
• Renibus Therapeutics, Inc., Southlake, TX, US

Prosecution history

• 27 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
• 27 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
• 25 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
• 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 28 Jan 2025 — PUBLISHED FOR OPPOSITION
• 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 02 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 02 Jan 2025 — EXAMINER'S AMENDMENT ENTERED
• 02 Jan 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 02 Jan 2025 — EXAMINERS AMENDMENT E-MAILED
• 02 Jan 2025 — EXAMINERS AMENDMENT -WRITTEN
• 30 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
• 30 Aug 2024 — NON-FINAL ACTION E-MAILED
• 30 Aug 2024 — NON-FINAL ACTION WRITTEN
• 23 Aug 2024 — ASSIGNED TO EXAMINER